{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:55:07Z","timestamp":1791320107919,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jviromet.2021.114221","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T20:07:15Z","timestamp":1624651635000},"page":"114221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research"],"prefix":"10.1016","volume":"295","author":[{"given":"Peng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2021.114221_bib0005","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2021.114221_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"Benton","year":"2020","journal-title":"Nature (London)"},{"key":"10.1016\/j.jviromet.2021.114221_bib0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jgm.1353","article-title":"Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer","volume":"11","author":"Carmo","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jviromet.2021.114221_bib0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2021.114221_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114221_bib0030","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114221_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2021.114221_bib0040","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. - PNAS"},{"key":"10.1016\/j.jviromet.2021.114221_bib0045","article-title":"Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa","author":"Houriiyah Tegally","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jviromet.2021.114221_bib0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.gendis.2020.07.006","article-title":"Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2","volume":"7","author":"Hu","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.jviromet.2021.114221_bib0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bj.2020.06.003","article-title":"Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development","volume":"43","author":"Huang","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.jviromet.2021.114221_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00068-9","article-title":"SARS-CoV-2 spike E484K mutation reduces antibody neutralisation","author":"Jangra","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jviromet.2021.114221_bib0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1525-0016(03)00073-X","article-title":"Efficient production of human FVIII in hemophilic mice using lentiviral vectors","volume":"7","author":"Kootstra","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jviromet.2021.114221_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2021.114221_bib0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2021.114221_bib0080","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.26.1.2002106","article-title":"Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020","volume":"26","author":"Leung","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jviromet.2021.114221_bib0085","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2021.114221_bib0090","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.cell.2021.02.042","article-title":"SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2021.114221_bib0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2021.114221_bib0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0215(20000815)87:4<574::AID-IJC18>3.0.CO;2-T","article-title":"Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response","volume":"87","author":"Meazza","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jviromet.2021.114221_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049566","article-title":"Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage","volume":"7","author":"Millet","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2021.114221_bib0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/22221751.2019.1571871","article-title":"Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities","volume":"8","author":"Nie","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jviromet.2021.114221_bib0115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jviromet.2021.114221_bib0120","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2021.114221_bib0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/21655979.2016.1176656","article-title":"Enhanced recombinant factor VII expression in Chinese hamster ovary cells by optimizing signal peptides and fed-batch medium","volume":"7","author":"Peng","year":"2016","journal-title":"Bioengineered"},{"key":"10.1016\/j.jviromet.2021.114221_bib0130","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc. Natl. Acad. Sci. - PNAS"},{"key":"10.1016\/j.jviromet.2021.114221_bib0135","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jviromet.2021.114221_bib0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12985-021-01490-7","article-title":"Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein","volume":"18","author":"Tani","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2021.114221_bib0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-385885-6.00009-2","article-title":"Coronavirus pathogenesis","volume":"81","author":"Weiss","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jviromet.2021.114221_bib0150","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/JVI.01650-10","article-title":"Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency","volume":"85","author":"Wolschek","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114221_bib0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2021.114221_bib0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/nat.2012.0405","article-title":"Inhibition of dengue virus 2 replication by artificial microRNAs targeting the conserved regions","volume":"23","author":"Xie","year":"2013","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jviromet.2021.114221_bib0165","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1080\/22221751.2020.1815589","article-title":"Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jviromet.2021.114221_bib0170","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2021.114221_bib0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jviromet.2021.114221_bib0180","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/JVI.79.2.918-926.2005","article-title":"Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha","volume":"79","author":"Yonezawa","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114221_bib0185","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1080\/21645515.2017.1325050","article-title":"A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system","volume":"13","author":"Zhang","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jviromet.2021.114221_bib0190","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","article-title":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera","volume":"184","author":"Zhou","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2021.114221_bib0195","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:53:59Z","timestamp":1759056839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093421001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":39,"alternative-id":["S0166093421001609"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114221","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114221"}}